Skip to main content

Oculis Holding AG

OCS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001953530

No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $322.0M in total; no superinvestor holds it.

Other share classesOCSAW

Q4 2025 vs. Q3 2025

How the institutions holding Oculis Holding AG changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of OCS: Q3 2025 compared with Q4 2025
MeasureQ3 2025Q4 2025Change
Holders2041+21
Shares10.9M18.1M+7.18M (+65.9%)
Value$191.7M$363.8M+$172.1M (+89.7%)

New holders (22)

Institutions that held Oculis Holding AG at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to OCS in Q4 2025
InstitutionSharesValue% of portfolio
Gildi - lifeyrissjodur2,447,985$50.3M22.73%
Wellington Management Group LLP1,356,179$27.1M0.00%
Saturn V Capital Management LLC516,761$10.3M1.89%
Perceptive Advisors LLC493,827$9.86M0.18%
Syquant Capital SAS192,722$3.85M0.47%
Folketrygdfondet182,800$3.65M0.08%
Propel Bio Management, LLC172,839$3.45M2.95%
Citadel Advisors LLC165,487$3.30M0.00%
NEXTBio Capital Management LP149,750$2.99M1.75%
Neo Ivy Capital Management54,771$2.55M0.40%
Simplify Asset Management Inc.98,765$1.97M0.03%
Alps Advisors Inc46,947$937.5K0.01%
Marshall Wace, LLP45,773$914.1K0.00%
HRT Financial LP43,914$876.0K0.00%
Renaissance Technologies LLC25,000$499.3K0.00%
Two Sigma Investments, LP24,444$488.1K0.00%
Millennium Management LLC15,641$312.4K0.00%
Gsa Capital Partners LLP13,042$260.0K0.02%
BNP Paribas Arbitrage, SA3,600$71.9K0.00%
JPMorgan Chase & Co3,180$63.5K0.00%
Jones Financial Companies LLLP210$4.19K0.00%
Citigroup Inc1$200.00%

Sold out (1)

Institutions that held Oculis Holding AG at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of OCS in Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Wolverine Asset Management LLC269$4.73K